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Nano-sized objects such as liposomes are modified by adsorption of biomolecules 
in biological fluids. The resulting corona critically changes nanoparticle behavior at 
cellular level. A better control of corona composition could allow to modulate uptake 
by cells. Within this context, in this work, liposomes of different charge were 
prepared by mixing negatively charged and zwitterionic lipids to different ratios. The 
series obtained was used as a model system with tailored surface properties to 
modulate corona composition and determine the effects on liposome interactions with 
cells. Uptake efficiency and uptake kinetics of the different liposomes were 
determined by flow cytometry and fluorescence imaging. Particular care was taken 
in optimizing the methods to isolate the corona forming in human serum to prevent 
liposome agglomeration and to exclude residual free proteins which could confuse 
the results. Thanks to the optimized methods, mass spectrometry of replicate corona 
isolations showed excellent reproducibility and this allowed semi -quantitative 
analysis to determine for each formulation the most abundant proteins in the corona. 
The results showed that by changing the fraction of zwitterionic and charged lipids 
in the bilayer, the amount and identity of the most abundant proteins adsorbed from 
serum differed. Interestingly, the formulations also showed very different uptake 
kinetics. Similar approaches can be used to tune lipid composition in a systematic 
way in order to obtain formulations with the desired corona and cell uptake behavior.  
 
1. Introduction 
    Nanomaterials have been widely applied to engineer novel delivery platforms for 
drugs, genes and therapies to treat various diseases [1,2]. Among them, liposomes, 
vesicles enclosed by a lipid bilayer, are undoubtedly among the most clinically 
established drug delivery systems in nanomedicine [3,4]. Since the introduction on 
the market in 1995 of the first liposomal formulation, Doxil, nowadays, several 
liposomal formulations have been approved for routine clinical use [4–6]. Thanks to 
the unique self-assembled structure and controllable synthetic identity, liposomes 
can be designed with varied size, charge and surface properties to enable efficient 











biodegradability make liposomes a versatile tool to load both hydrophilic or 
hydrophobic agents for diagnosis and therapy [3,6].   
    Once introduced into biological fluids, nanoscale objects such as liposomes adsorb 
numerous proteins and biomolecules on their surface forming a layer known as 
“protein corona” [7,8] . This layer affects nanoparticle charge, size and surface 
properties and confers to nanomaterials new biological properties [9,10], which 
affect the following nanoparticle performance, such as distribution, toxicity, cellular 
internalization and final fate [9,11–13]. Several studies have described the corona 
forming on liposomes [14–19]. For instance, Caracciolo et al. showed that lipid 
composition can be manipulated in order to affect corona composition [14] and other 
works showed how the corona changes once liposomes are applied in vivo [15].  
    Additionally, different efforts have been made to correlate corona composition 
with nanoparticle uptake efficiency by cells. Similar studies allow to identify corona 
proteins or protein patterns correlating to higher or lower uptake by cells and/or 
different fate in vivo. For instance, Ritz et al. showed that apoA4 or apoC3 in the 
corona of polystyrene nanoparticles correlated with lower uptake by cells [20]. Using 
liposomes, Bigdeli et al. used quantitative structure–activity relationship (QSAR) in 
order to connect different physico-chemical properties of the particles, including 
their corona, with uptake and viability in cells [16]. Lazarovits et al., instead, used 
supervised learning and mass spectrometry of corona composition to predict the in 
vivo fate of nanoparticles [13].  
    Because of the difficulty in predicting and controlling corona formation, strategies 
such as poly(ethylene glycol) (PEG) modification have been used to make carriers 
“stealth”, and try to avoid protein corona formation [21,22]. However, PEGylation 
cannot completely suppress protein adsorption, and recent studies suggested that the 
stealth properties of PEG are actually conferred by a specific protein, i.e. clusterin, 
which absorbs in the corona of PEGylated nanocarriers [23]. At the same time, it is 
also emerging that corona proteins can be actively recognized by cell receptors, thus 
the corona-nanoparticle complexes constitute the real biological unit interacting with 
cells [24,25]. For instance, it has been shown that the proteins adsorbed on 100 nm 
silica nanoparticles can present functional epitopes from low-density lipoprotein and 




Prapainop et al. also reported that misfolding of corona proteins adsorbing on a s mall 
molecule modified quantum dot led to cell specific receptor -mediated internalization 
[26]. In light of similar observations, it has been proposed that rather than trying to 
limit its formation, the protein corona could be exploited to enable novel 
opportunities for the design of targeted nanomedicines, as well as for the discovery 
of biomarkers [25,27–29]. 
    Overall, whether exploring strategies to control corona formation or to exploit its 
biological properties for novel applications, it is clear that a comprehensive and 
accurate characterization of the corona, including the factors affecting its 
composition and the resulting corona effects on the nanomaterial outcomes at 
organism and cell levels is essential. 
    Within this context, in this work, we chose liposome as a nanomedicine model to 
prepare a series of nanosized carriers with tailored surface properties. While in many 
examples in literature, liposomes of different composition and their coronas were  
compared [14,16,18], here a liposome series of tailored surface properties was 
prepared by mixing common charged and zwitterionic lipids in different ratios in a 
systematic way, and, in this way, to tune the resulting coronas in human serum. Then, 
the stability of the different liposomes in biological conditions was tested in order to 
select stable formulations and in this way avoid confusing results for the corona 
forming on agglomerates. Liposome uptake kinetics were obtained by f low cytometry, 
using HeLa cells as a common cell model, in order to determine the effect of lipid 
composition and resulting corona in human serum on uptake efficiency by cells. 
Particular efforts were spent in the optimization of the methods for corona iso lation 
in order to recover well-dispersed liposome-corona complexes and to avoid 
contamination of residual free proteins from serum after corona isolation, which 
could confuse the results. Thus, SDS-PAGE and protein identification by mass 
spectrometry were used to characterize the corona forming on the different liposomes. 
Particular attention was paid in repeating corona isolation and identification by mass 
spectrometry multiple times for each formulation in order to confirm reproducibility 
with the optimized isolation methods and to obtain robust values of relative protein 
abundance to allow statistical analysis. Thanks to this and the optimized methods, 











enriched proteins determined. This allowed us to connect the abundance of specific 
proteins in the corona forming on the different liposomes with the uptake kinetics in 
cells.  
 
2. Materials and methods 
2.1 Preparation of liposomes 
    The zwitterionic lipids 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), cationic lipids 1,2-
dioleoyl-3-trimethylammonium-propane (DOTAP) and 3ß-[N-(N',N'-
dimethylaminoethane)-carbamoyl]cholesterol (DC CHOL), anionic lipid 1,2-
dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DOPG) and cholesterol were 
purchased from Avanti Polar Lipids. To prepare different liposomal formulations, 10 
mg lipid mixtures at different molar ratios were prepared and dissolved in chloroform. 
The composition of all formulations tested is given in Supplementary Table S1. Then, 
the solvent was evaporated using a nitrogen stream and then by incubation under 
vacuum overnight. The lipid films were hydrated with 1 ml 25 mM sulforhodamine 
B (SRB) in PBS at room temperature and vortexed to produce fluorescently labeled 
multilamellar liposomes. Small unilamellar liposomes were obtained by performing 
8 freeze-thaw cycles followed by extrusion 21 times through a 0.1 µm polycarbonate 
membrane using the Avanti Mini-Extruder (Avanti Polar Lipids). Residual free SRB 
was removed by centrifugation with a Zeba  Spin Desalting Column, 7K MWCO 
(Thermo Fisher Scientific). The obtained unilamellar liposomes were stored at 4 °C 
and were used only for up to 1 month after preparation.  
2.2 Protein corona formation and isolation  
    In order to allow corona formation, 0.5 mg/ml liposomes were mixed with fetal 
bovine serum (FBS) (Gibco Thermo Fisher Scientific) or human serum from pooled 
donors (TCS Biosciences Ltd) at a final concentration of 40 mg/ml and were 
incubated in a Thermo-Shaker (Grant Instruments Ltd) at 37 °C, 250 rpm. After 60 
min incubation, corona-coated liposomes were separated from the excess serum 
proteins by size exclusion chromatography using a Sepharose CL-4B (Sigma-Aldrich) 




collected up to a total volume of 15 ml (30 fractions) and their absorption at 280 nm 
and 565 nm were measured using a NanoDrop One Microvolume UV-Vis 
Spectrophotometer (Thermo Fisher Scientific) in order to determine, respectively, 
the protein and SRB elution profiles. The fractions containing SRB-labelled corona-
coated liposomes (roughly fractions 7-10) were pooled together and concentrated 
using a Vivaspin 6 centrifugal concentrator (10K MWCO, Sartorius) by 
centrifugation at 1600 g at 4 °C until the final volume of the solution was less than 
0.2 ml.  
    In order to prepare particle-depleted human serum by removing larger objects 
eluting in the same fractions as the liposomes, 1  ml human serum was injected in the 
column and fractions were collected as described above. Then, the fractions 
corresponding to larger particles were discarded and all other fractions (roughly from 
11 to 30) were pooled together and the total protein content determined using a Bio-
Rad DC protein assay (Bio-Rad Laboratories, Inc.) as described below. The particle -
depleted serum was then used to prepare liposome-corona complexes. Given that the 
corona composition changes when the ratio between the total nanoparticle surface 
area and protein content is varied [30], in order to apply the same conditions as for 
the isolation in full FBS or full HS, 0.075 mg/ml liposomes were dispersed in 6 mg/ml 
serum. Then, the isolation of corona-coated liposomes was performed as described 
above. 
2.3 Size and zeta potential measurements 
    Size distribution and zeta potential of the liposomes dispersed in various media 
were measured using a Malvern Zetasizer Nano ZS (Malvern Instruments Ltd., USA). 
Samples at a final concentration of  50 µg/ml were prepared by  dilution of the 
liposome stock solution in different media, including MilliQ water, PBS, and MEM 
cell culture medium supplemented with 10% v/v FBS (roughly corresponding to 4 
mg/ml) (cMEM) or with 4 mg/ml human serum (hsMEM) and measured just after 
dispersion. For size measurements, each sample was measured 3 times at 20 °C with 
automatic setting for the measurement duration. To measure the zeta potential, 
disposable folded capillary cells were used and 3 measurements per sample were 











monomodal analysis. The size distribution and zeta potential of the corona-coated 
liposomes after the isolation procedure were also determined in the same way.   
2.4 Protein assay and lipid assay 
    To compare the protein-binding capacity of the different liposome formulations, 
the protein/lipid ratio (µg of protein/µmol of lipid) was calculated by determining 
the amount of proteins and lipids in the corona-coated liposomes after isolation from 
free proteins and spin-concentration. The amount of proteins in the corona was 
quantified using the Bio-Rad DC protein assay (Bio-Rad Laboratories, Inc.) using 
dilutions of bovine serum albumin (BSA) at known concentrations as a standard. 
Briefly, standard solutions containing 0.1 mg/ml to 3.2 mg/ml BSA were prepared, 
then 5 µL sample or standards were mixed with the working reagent. After 15 min, 
the absorbance at 650 nm was read using a ThermoMAX microplate reader 
(Molecular Devices, LLC). Then, the protein concentration was calculated according 
to the BSA standard curve. The lipid concentration was determined via the Stewart 
assay. For this, a ferrothiocyanate reagent was prepared by dissolving 27.0 mg ferric 
chloride hexahydrate (Sigma Aldrich) and 30.4 mg ammonium thiocyanate (Sigma 
Aldrich) in 1 ml Milli-Q water. Then, 20 µL liposome samples or lipid standards 
(from 0 mg/ml to 1 mg/ml) were mixed with 1 ml chloroform and 1 ml 
ferrothiocyanate reagent and vortexed for 60 s followed by centrifugation at 300 g 
for 10 min. 900 µL of the organic phase was transferred to a quartz cuvette, and the 
absorbance at 470 nm was measured on a Unicam UV500 Spectrophotometer 
(Unicam Instruments). Lipid concentrations were calculated according to a standard 
curve obtained with the same lipid from samples at known concentrations. The 
protein/lipid ratios were determined. The average and standard  deviation of the 
results obtained in 3 independent experiments was calculated.  
2.5 SDS-PAGE electrophoresis  
In order to separate the isolated corona proteins, corona-coated liposomes 
corresponding to 0.05 µmol lipid were mixed with 4× loading buffer (con taining 200 
mM Tris-HCl, 400 mM DTT, 8% SDS, 0.4% bromophenol blue and 40% glycerol) to 
a final volume of 40 µL and heated for 5 min at 95 °C. 20 µg human serum was also 
loaded as control using the same procedure. Samples were then loaded onto a 10% 




stained by using a solution containing 0.1% Coomassie blue R-250 in a water–
methanol–glacial acetic acid (5:4:1) mixture with gentle agitation, followed by 
destaining in hot ultrapure water. Images were captured using a ChemiDoc XRS (Bio-
Rad).  
2.6 Protein digestion and peptide desalting  
    Mass spectrometry was used to identify the corona proteins isolated on the 
liposomes after dispersion in particle-depleted human serum, and –as a reference – 
the proteins in full human serum. Protein digestion was performed as described in 
literature [31]. Briefly, after corona formation and isolation, samples containing 10 
µg corona proteins and –as a control - the same amount of human serum proteins 
were resuspended in 40 µL of 8 M urea in 50 mM NH4HCO3 (Sigma-Aldrich) and 
incubated for 30 min at room temperature. The protein solutions were then reduced 
by adding 2 µL 200 mM DL-dithiothreitol (DTT) (Sigma-Aldrich) and incubation for 
30 min at room temperature, followed by alkylation with 8 µL 200 mM iodoacetamide 
(Sigma-Aldrich) for 30 min. 8 µL 200 mM DTT was added, and the solution was kept 
at 56 °C for 30 min. The sample solution was then diluted with 50 mM NH 4HCO3 to 
a final urea concentration of 1 M, and 2 µg trypsin (Promega Corporation) was added. 
    After overnight digestion with trypsin at 37 °C, the reaction was stopped by 
addition of trifluoroacetic acid (TFA) to 0.4% (v/v) final concentration. The solutions 
were dried in an Eppendorf centrifugal vacuum concentrator (Sigma-Aldrich) and 
resuspended in 40 µL 0.1% TFA. The digested samples were desalted and lipids were 
removed using a C18 ZipTip (Merck Millipore). Briefly, tips were washed with 
acetonitrile (ACN) 3 times and equilibrated with 0.1% TFA. Samples were then 
loaded onto tips, followed by washing the tips with 0.1% TFA. Peptides were then 
eluted with 100 µL of 0.1% TFA/50% ACN (50:50, v/v), and the solvent was removed 
using a centrifugal vacuum concentrator. The dried peptides were dissolved in 10 µL 
0.1% HCOOH (v/v) for LC/MS analysis.  
2.7 Shotgun LC/MS-MS analysis, data processing and bioinformatics analysis  
    Tryptic peptides were analyzed with an UltiMate 3000 RSLC UHPLC system 
(Dionex) linked to an Orbitrap Q Exactive Plus mass spectrometer (Thermo Fisher 











raw data were analysed with PEAKS Studio software (version 8.5) [32] using the 
SwissProt human database (20197 entries; downloaded on July 27 th, 2016). The 
detailed protocol is included in Supplementary materials.  
    A relative quantitation of the identified proteins was performed by dete rmining 
the ion peak area (Area), which was the sum of the areas of all unique peptides 
mapping to the protein group. For each identified protein, the protein Area was 
normalized by the protein mass and expressed as the relative protein abundance 
according to the following equation: 
Areax = [(Area/Mw)x / ∑ (Area/Mw)𝑛𝑖=1 i] × 100                                  (1) 
    Based on the calculated Area value, data were further analyzed and visualized with 
an in-house developed script in R (version 3.4.3) and R Studio (version 1. 0.143). 
The quantitative Area values were subjected to median scale normalization [33].  
    In order to determine the most abundant proteins in the corona, the Rank Product 
method [34] was applied to rank the identified proteins as follows: in Fig. 6A and 
Supplementary Fig. S7 to rank the most abundant corona proteins identified on all of 
the 3 different formulations (3 liposomes with 3 replicate isolations each, thus 9 
corona samples in total) and in Supplementary Figs. S8A-C instead to rank the corona 
proteins of each liposome (in 3 replicate isolations), thus the corona proteins of 
DOPC liposomes in Supplementary Fig. S8A, DOPC/G liposomes in Fig. S8B and 
DOPG liposomes in Fig. S8C . The detailed protocol is included in Supplementary 
materials.   
2.8 Cell culture 
    HeLa cells (ATCC CCL-2) were cultured in MEM (Gibco Thermo fisher Scientific) 
supplemented with 10% v/v FBS (roughly corresponding to 4 mg/ml proteins) 
(complete cell culture medium, cMEM) in a humidified atmosphere containing 5% 
CO2 at 37 °C. Cells were passaged two to three times a week and used for up to 
maximum 20 passages. Cells were tested against mycoplasma monthly to exclude 
mycoplasma contamination. 




    Uptake of the different liposomes in different media by HeLa cells was determined 
by flow cytometry. HeLa cells were seeded at a density of 5 × 10 4 cells/well in a 24-
well plate and incubated in cMEM for 24 h. Cells were then washed with serum free 
medium three times and incubated with 50 µg/ml liposome dispersions prepared by 
dilution of the liposome stock in to cMEM or hsMEM. After exposure to the liposome, 
HeLa cells were washed once with cMEM and twice with PBS in order t o remove 
excess liposomes outside the cells and harvested by incubation for 5 minutes with 
0.05% trypsin-EDTA at 37 ˚C. Cells were then centrifuged at 300 g for 5 minutes, 
resuspended in PBS and measured immediately using a BD FACSArray (BD 
Biosciences) with a 532 nm laser. Gates were set in the forward and side scattering 
double scatter plots to exclude dead cells and cell doublets. For each condition 2 
samples were prepared and 2 × 104 cells were recorded for each sample. Data were 
analyzed with FlowJo software (FlowJo, LLC), and the average of the median 
fluorescence intensity and standard deviation over the replicates calculated.  
    In order to measure potential uptake in energy depleted cells, cells were incubated 
with 5 mg/ml sodium azide (Merck). The detailed protocol is given in Supplementary 
materials. 
2.10 Fluorescence imaging 
    For fluorescence microscopy, 1.5 × 105 cells were seeded in 35 mm dishes with a 
170 µm thick glass bottom. To visualize the lysosomes, cells were incubated for 30 
min with 100 nM LysoTracker Deep Red in cMEM and nuclei stained by incubation 
with 1 µg/ml Hoechst 33342 Solution in cMEM for 5 min (both from Thermo Fisher 
Scientific). Cells were imaged using a Leica TCS SP8 fluorescence confocal 
microscope (Leica Microsystems) or a DeltaVision Elite (GE Healthcare Life 
Science). ImageJ software (http://www.fiji .sc) was used for image processing and 
brightness and contrast were adjusted using the same setting for all samples in order 
to allow better visualization. The detailed protocols are included in Supplementary 
materials. 
2.11 Statistical analysis 
    One way ANOVA analysis was used to test the difference of each identified corona 











correction for multiple testing, the calculated p values were considered to be 
significant for p value ≤ 0.01.  
    All cellular uptake data are displayed as the average and standard deviation over 
2 replicates of the median cells fluorescence obtained by flow cytometry.  
 
Figure 1. Physicochemical characterization of liposomes. (A) Size distribution by in tensity 
(diameter, nm) of liposomes in different media. 50 μg/ml liposomes in PBS, cMEM and hsMEM 
were characterized by DLS as described in Materials and methods. (B) Zeta potential of liposome 
dispersions in different media. 50 μg/ml liposomes were incuba ted in PBS, cMEM and hsMEM and 
their zeta potential was measured as described in Materials and methods. The results are the average 
and standard deviation over 3 measurements. (C-D) Liposome stability in cMEM (C) and hsMEM 
(D). 50 μg/ml liposomes were dispersed in cMEM (C) or hsMEM (D) and their size distribution was 




3. Results and discussion 
3.1 Liposome formulation and characterization 
    Liposome series were prepared by gradually mixing lipids of different charge in 
different ratio. All the liposome formulations tested are listed in Supplementary 
Table S1. Sulforhodamine B (SRB) was chosen as a hydrophilic dye to label all the 
different formulations and in this way quantify their uptake and localization inside 
cells. This was preferred to using a lipid dye, because polar molecules such as SRB, 
once loaded in the inner aqueous volume of liposomes are unable to cross the 
liposome and cell membrane by simple diffusion. Additionally, similar hydrophilic 
labels cannot easily transfer from the liposome into cell membranes, as observed with 
several hydrophobic dyes [35]. Fluorescence measurements showed that all 
liposomes encapsulated comparable amounts of SRB, with the DOPC liposomes 
usually showing slightly higher encapsulation efficiency. Cholesterol was added in 
order to improve liposome stability in biological conditions: exposure to biological 
media such as serum is known to affect bilayer stability, especially at higher protein 
concentration, as used here. This could lead to leakage of the delivered drugs or –in 
our case – the fluorescent label SRB from the inner volume, which could confuse 
uptake quantification [36]. 
    In order to allow corona formation, a medium supplemented with human serum 
was used as a more relevant source of serum when studying uptake in human cells, 
as in this case. Additional results for liposomes dispersed in a standard cell culture 
medium supplemented with fetal bovine serum (FBS) were also included as a 
reference for comparison. 
All liposomes were characterized by dynamic light scattering (DLS) and ζ -
potential measurements after extrusion and after dispersion in relevant biological 
fluids, including cell culture medium (MEM) supplemented with roughly 4 mg/ml of 
either fetal bovine serum (standard 10% FBS complete cell culture medium, cMEM) 
or human serum (here referred to as hsMEM). After preparation, all formulations 
showed narrow size distributions with very low polydispersity indexes in the range 
of 0.1-0.3, confirming that preparation by extrusion allowed us to obtain liposomes 











medium supplemented with serum, for the zwitterionic and anionic liposomes 
homogeneous dispersions could be obtained in both cMEM and hsMEM (Fig. 1A). 
In some cases, a small peak around 10 nm was visible from the excess free proteins 
in solution. For all formulations, the zeta potential in PBS reflected the different 
lipid composition, but once introduced in medium with serum all converged towards 
neutrality, independently of the original surface charge, as expected as a consequence 
of protein adsorption on the surface and corona formation (Fig. 1B and 
Supplementary Fig. S1) [9]. Additionally, in both cell culture media, the dispersions 
of the optimized liposome formulations remained stable for up to 24 h under 
biological conditions (37 ºC, 5% CO2 as used for experiments with cells) (Fig. 1C-
D). The cationic liposomes instead showed strong aggregation in both biological 
media (Supplementary Fig. S1). It is known that bridging flocculation can occur 
between negatively charged proteins and positively charged nanoparticles [37]. 
Hence, in order to avoid confusing results for the corona forming on agglomerates, 
only the series with the zwitterionic DOPC and anionic DOPG lipids mixed in 
different ratios was used for further studies.  
 
3.2 Uptake efficiency by cells and uptake kinetics  
    In order to investigate cellular uptake behavior of the liposome series, HeLa cells 
were selected as a standard cell model commonly applied for similar liposome uptake 
and corona studies [16,38]. As a first step, flow cytometry was used to measure the 
median fluorescence intensity of cells after exposure to liposomes for different times. 
Because of their comparable fluorescence, liposomes were exposed to the same total 
amount of lipids, obtained as described in the Materials and methods. Uptake kinetics 
were determined for both liposomes dispersed in hsMEM and cMEM, and also 
liposomes dispersed in higher concentration of human serum (Fig. 2A and 
Supplementary Fig. S2A and B, respectively).  
    When comparing uptake efficiency for the different formulations (Fig. 2A), the 
zwitterionic DOPC liposomes showed lower uptake efficiency by cells, and their 
uptake increased with increasing exposure time. On the contrary, the kinetics of 
uptake of the anionic DOPC/G and DOPG liposomes differed strongly, with much 




showing the highest efficiency), followed by a progressive decrease in the average 
cell fluorescence, converging to similar levels for the two formulations over 24 hours. 
Zwitterionic objects are known to bind less to cells in comparisons to charged 
particles, thus it is generally observed that increasing particle charge can improve 
their uptake efficiency. For instance, Lee et al. [39] found that the endocytosis of 
anionic liposomes including phosphatidylglycerol (PG), phosphatidylserine (PS) or 
phosphatidic acid (PA) was faster and more efficient than for zwitterionic liposomes. 
Allen et al. also observed that for several liposomes (e.g. liposomes containing PS 
or various gangliosides) the uptake efficiency in bone marrow macrophages in vitro 
was positively correlated with the clearance by the reticuloendothelial system 
observed in vivo [40]. However, as mentioned, once liposomes were introduced to 
medium with serum, the resulting corona-nanoparticle complexes, all converged to 
equivalent zeta potential values, regardless of the starting charge (Fig. 1B) [9]. This 
is an important consequence of corona formation, still often overlooked, that should 
be kept in mind when tuning nanoparticle charge in the attempt of improving uptake 
efficiency. Given the similar zeta potential of the different formulations once 
dispersed in medium with serum, the different uptake efficiency in the first hours of 
exposure is likely due to differences in affinities and binding capacity between ce ll 
membrane components and liposomes, possibly mediated by specific differences in 
corona composition.  
    It is interesting to note also that the uptake of liposomes was lower in medium 
with human serum than with bovine serum (as observed when comparing the results 
in Supplementary Fig. 2A and Fig. 2A), and uptake levels decreased further when 
increasing human serum concentration in the medium (Supplementary Fig S2B). It is 
known that protein concentration and also protein source both have significant 
implications on nanoparticle uptake. Kim et al. [41] for instance showed that 
increasing serum concentration decreased uptake of polystyrene nanoparticles, and 
Schöttler et al. [42] showed that dispersion in human serum or plasma reduced the 
uptake of amino-modified polystyrene nanoparticle dramatically compared the 
uptake levels in medium with bovine serum. 
As a next step, in order to determine whether liposome uptake was energy 











used to deplete cell energy (Fig. 2B-D for liposome dispersions in hsMEM and 
Supplementary Fig. 2S for dispersions in cMEM or higher human serum 
concentration). The results showed that exposure to sodium azide lowered strongly 
uptake levels, which indicated that liposome uptake was energy dependent. This 
suggested that liposomes were internalized by cells as intact nanoparticles via some 
active mechanism of endocytosis, and not by a passive mechanism of direct fusion 
with the cell membrane. Transport inhibitors and other methods are required in order 
to determine the mechanism of uptake for each formulation, as we analyzed in detail 
in a separate study (Yang et al., in Chapter 4). 
 
Figure 2. Uptake of liposomes in hsMEM by HeLa cells. (A) Uptake kinetics of liposomes in 
hsMEM. HeLa cells were exposed to 50 μg/ml DOPC, DOPC /G and DOPG liposomes in hsMEM, 
and after different exposure times, cells were collected for flow cytometry measurement as 
described in Materials and methods. (B-D) Uptake of DOPC (B), DOPC/G (C) and DOPG (D) 
liposomes in energy depleted cells. Briefly, af ter 30 min pre-incubation with 5 mg/ml sodium azide, 
HeLa cells were exposed to 50 μg/ml liposome in standard hsMEM or hsMEM containing 5 mg/ml 
sodium azide, followed by cell fluorescence measurement by flow cytometry (see Materials and 
methods for details). In all panels, the results are the average and standard deviation over 2 
replicates of the cell fluorescence intensity obtained by flow cytometry (error bars are included in 
all graphs but in some cases are not visible because very small).  
 
    In order to confirm that the measured cell fluorescence was due to the active 




free SRB or SRB leaking from the liposomes, additional controls for liposome 
stability were performed (Supplementary Fig. S3). First, size exclusion 
chromatography (SEC) was used to separate eventual free dye leaking from the 
liposome. This confirmed excellent removal of residual free SRB after liposome 
preparation and no leaking in PBS (Supplementary Fig. S3A). The same was repeated 
after exposure to human serum (40 mg/ml) to test liposome stability and eventual 
leakage after corona formation. SEC showed that for DOPC/G and DOPC liposomes 
most SRB remained encapsulated in the liposomes, while dye leakage was  observed 
for DOPG liposomes (Supplementary Fig. S3B), possibly contributing to its peculiar 
uptake kinetics.  
    However, as shown in Supplementary Fig. S3C, the cellular uptake of the same 
amount of free SRB was much lower, and particularly in comparison to DOPG and 
DOPC/G liposomes. Additionally, exposure to sodium azide led to only 25% uptake 
reduction for free SRB (as opposed to 50% for DOPC and 70-80% for DOPC/G and 
DOPG liposomes), possibly also because of compromised cell membrane 
permeability in the energy depleted cells (see Supplementary Fig. S3 for details). 
Altogether, the lower uptake efficiency of free SRB and the lower effect of sodium 
azide confirmed that the fluorescence measured in cells exposed to the liposomes 
was primarily resulting from the uptake of SRB encapsulated in the liposomes. On 
the contrary, when a lipid dye was used to label the liposomes, almost no reduction 
of uptake was observed in the presence of sodium azide (Supplementary Fig. S3D). 
This possibly resulted from the transfer of the lipid dye from the liposomes to the 
cell membrane [35,39]. Because of this observation, to exclude similar effects which 
could confuse uptake results, liposomes labelled with SRB were chosen for the study.  
Next, fluorescence microscopy was used to determine the final intracellular 
location of the liposomes after 3 h exposure (Fig. 3 for experiments in hsMEM and 
Supplementary Figs. S4A-C for comparable experiments in cMEM). Imaging 
indicated that the DOPC/G and DOPG liposomes in cMEM or hsMEM colocalized 
with intracellular vesicles stained by LysoTracker, confirming that these liposomes 
were efficiently trafficked along the endosomal  pathway by cells and mostly 
accumulated in the perinuclear area in the lysosomes. In agreement with the lower 











setting almost no signal from the DOPC liposomes could be detected (Fig. 3 and 
Supplementary Figs. S4A-C). However, by increasing gain settings, uptake and 
colocalization with LysoTracker were observed also in cells exposed to the DOPC 
liposomes (Supplementary Fig. S4E), confirming internalization and trafficking 
along the endo-lysosomal pathway also for this formulation. Interestingly, in 
comparison, cells exposed to the same amount of free SRB for the same time showed 
almost no signal, and no clear intracellular SRB could be detected even when imaging 
cells with increased gain (Supplementary Figs. S4D and F). In line with the flow 
cytometry results with free SRB, this confirmed once more that the SRB signal 
detected in cells exposed to the liposomes comes primarily from the active delivery 
of SRB encapsulated in the liposomes, rather than free dye released prior to or during 
uptake. 
  
Figure 3. Fluorescence microscopy images of HeLa cells exposed to liposomes in hsMEM. Briefly, 
HeLa cells were exposed for 3 h to 50 μg/ml SRB -labelled DOPC, DOPC/G or DOPG liposomes 
and imaged using the same settings to allow comparison of the uptake levels by cel ls in hsMEM. 
Blue: Hoechst stained nuclei. Red: SRB stained liposomes or free SRB. Green: LysoTracker stained 
lysosomes (see Materials and methods for details and Supplementary Fig. S4 for images at different 




    In summary, all the liposomes were internalized by cells as intact nanoparticles 
via energy-dependent pathways, and trafficked along the endo-lysosomal pathway,  
delivering into cells higher levels of SRB than what obtained in cells exposed to the 
same amount of free dye (much higher in the case of the DOPG and DOPC/G 
liposomes). However, uptake efficiency and kinetics varied strongly for the 
negatively-charged and zwitterionic formulations, likely as a result of specific 
interactions of corona proteins with cells.  
 
3.3 Isolation and characterization of protein corona coated liposomes  
    As a next step, in order to connect the observed differences in cellular uptake 
behavior with potential differences in corona composition, corona-coated liposomes 
were isolated from the excess serum to allow identification and quantification of 
protein corona composition [43,44]. As a first step, liposomes dispersed in medium 
with FBS were used for optimization of the isolation procedure.  
 
Figure 4. Isolation and characterization of liposome-corona complexes. (A) Scheme of corona 
isolation by size exclusion chromatography (SEC) (see Materials and methods for details). (B) 











ml 0.5 mg/ml DOPC liposome in 40 mg/ml FBS (orange) were isolated by SEC as described in 
Materials and methods. The same amounts of FBS (green) and liposomes (blue) alone were also 
loaded in the column for comparison. Then, fractions were collected and their absorbance at 280 
nm measured to obtain the protein elution profile. (C) Size distribut ion by intensity of liposome 
dispersions in PBS and the corresponding corona-coated liposomes in FBS after corona isolation. 
The size distributions were obtained by DLS immediately after the corona fractions were pooled 
together and concentrated as described in the Materials and methods.  
 
    Although centrifugation is often used for nanoparticle-corona isolation, this 
method is not best suited for nanomaterials  of smaller size or with low density such 
as liposomes, as sedimentation is difficult and using h igher centrifugal forces could 
result in strong agglomeration which could affect corona composition. For our 
formulations, in fact, centrifugation led to strong agglomeration (Supplementary Fig. 
S5) [7,9]. Hence, in order to avoid to study the corona forming on agglomerates, 
additional efforts were spent in the optimization of other methods to allow isolation 
of well dispersed corona-coated liposomes. This was achieved by isolation via size 
exclusion chromatography (SEC). As depicted in Fig. 4A, the corona proteins are 
carried by the liposomes and elute in earlier fractions than free serum. Thus, the 
absorbance at 280 nm and the fluorescence of SRB were monitored to  determine the 
fractions in which the fluorescently labelled corona-coated liposomes eluted. 
Comparison of the elution profiles of liposomes alone, serum alone and their mixture 
confirmed successful isolation of corona-coated liposomes (Fig. 4B). The fractions 
containing liposomes were pooled together and concentrated by membrane 
ultrafiltration. DLS measurements confirmed isolation of well -dispersed corona-
coated liposomes, with a small increase in size distribution as a consequence of 
corona formation, and overall still very low polydispersity (Fig. 4C).  
    The optimized procedure for corona isolation was then used for samples dispersed 
in human serum. However, different from FBS, when using human serum, we 
observed that some components eluted out in the same fractions as the liposomes 
(Supplementary Figs. S6A-B). DLS results confirmed that these fractions contained 
particles with sizes comparable to the liposomes (between 100-200 nm), and SDS-
PAGE images showed that they also contained many proteins (Supp lementary Figs. 
S6C-D). Thus, human serum contains protein particles which have similar size as the 




sources of human serum pooled from donors (data not shown). In agreement with o ur 
results, Caby et al. [45] observed that exosomes-like particles are present in plasma 
samples of healthy donors, with sizes around 100 nm and containing tetraspanin 
molecules and other known exosomes enriched proteins. It is likely that these objects 
also included protein aggregates formed after freezing the s erum for storage. The 
presence of these aggregates and/or particles in the same fractions in which 
liposomes elute can contaminate the isolated corona-coated liposomes and their 
proteins can confuse corona protein identification. Similar issue were reporte d by 
Kristensen et al. [46]. Different approaches can be followed to address this issue, 
also depending on the purpose of the study [29,46,47]. In our case, in order to avoid 
contamination of corona proteins by exosomes or protein aggregates in the serum, 
SEC was used to first remove particles and aggregates from the serum in the fractions 
corresponding to the liposomes. All other serum fractions were pooled together 
(excluding those containing particles) and SEC was performed again to confirm 
efficient particle removal (Fig. 5A). This will be referred to as particle-depleted 
human serum (particle-depleted HS). Although the removal of a (very small) fraction 
of proteins and protein aggregates is likely to affect the final corona composition, 
for the purpose of this study this approach was preferred in order to ensure that after 
liposome isolation the proteins identified only belonged to their corona, and no 
contamination of other protein particles or aggregates was present. Then, liposomes 
were incubated 1 h with the particle-depleted HS and finally the corona-coated 
liposomes were isolated by SEC (Fig. 5B. We note that most SRB eluted in the same 
fractions as the liposomes, confirming stability of DOPC also after incubation in 
serum). DLS measurements after corona isolation showed a small shift to larger sizes 
which confirmed corona formation on the liposomes (Fig. 5C). Additionally, 
dispersions with very narrow size distributions were obtained, indicating that the 
liposome remained intact and highly homogeneous after corona formation and 
isolation.  
In order to qualitatively compare corona properties for the three different 
liposomes, the protein binding capacity (PBC) defined as the amount of absorbed 
proteins (µg) per micromole of lipid was evaluated, and gel electrophoresi s (SDS-











for details). As shown in Fig. 5D, DOPC and DOPC/G liposomes showed comparable 
PBC, while the PBC of DOPG liposomes was significantly higher. This indicated that 
much more proteins adsorbed on the DOPG liposome surface once introduced in a 
biological environment in comparison to the other formulations. Thus, addition of 
increasing amount of the zwitterionic DOPC lipid resulted in liposomes with lower 
zeta potential (Fig. 1B) and in turns this resulted in lower protein binding (Fig. 5D), 
as well as lower uptake efficiency in cells (Fig. 2A).  
 
Figure 5. Preparation of particle-depleted human serum (particle-depleted HS) and isolation of 
corona-coated liposomes. (A) Elution profiles of human serum after depletion of larger particles by 
SEC. Briefly, SEC was used to remove larger particles from human serum as described in the 
Materials and methods, then 1 ml particle -depleted HS was loaded again into a Sepharose CL-4B 
column and the protein elution profile was obtained. (B) Elution profile of DOPC liposomes after 1 
h incubation with particle-depleted HS. Briefly, 0.075 mg/ml liposomes were mixed with 6 mg/ml 




elution profiles at 280 and 565 nm determined as described in Materials and methods. (C) DLS size 
distributions by intensity of DOPC, DOPC/G and DOPG liposomes in PBS and the corresponding 
corona-coated liposomes in particle-depleted HS after corona isolation. (D) Comparison of the 
amount of protein absorbed on DOPC, DOPC/G and DOPG liposomes after corona isolation . The 
protein binding capacity (PBC) was defined as the amount of absorbed proteins (μg) per micromole 
of lipid. The results are the average and standard deviation from three independent corona isolation 
experiments. (E) SDS-PAGE image of corona proteins recovered from DOPC, DOPC/G and DOPG 
liposomes in particle-depleted HS. The same amount of lipids was loaded in each lane (0.05 μmol), 
together with 20 μg full human serum and particle -depleted HS as controls.  
 
SDS-PAGE was then used to separate the corona recovered from the same amount 
of liposomes. Full serum and the particle-depleted HS were also loaded as a control, 
showing no major differences in the bands detected (Fig. 5E). Instead, the corona 
proteins identified on the three liposomes differed strongly, mainly showing 
differences in their intensities (Fig. 5E). Indeed, in agreement with the PBC 
evaluation, higher band intensities were observed for liposomes with increasing 
percentage of the charged DOPG lipid in their formulation. In general, liposome s 
with a charged surface tend to have stronger protein adsorption than the ones with 
neutral surface [48], which is consistent with our results. Zwitterionic modifications 
are in fact used as alternative to PEGylation to reduce protein binding [49] and 
usually zwitterionic particles also show lower cellular adhesion [49], while 
liposomes possessing charged headgroups have been found to activate the 
complement more efficiently and be cleared faster [50], especially the one with 
cationic lipids [48]. Our results are in agreement with these observations.  
 
3.4 Identification of corona proteins and comparative analysis of corona 
composition 
    The next step was to identify the recovered corona proteins and analyze 
differences in corona composition for the different liposome formulations, in order 
to connect the corona composition to the observed differences in uptake behavior on 
cells. For this, a quantitative characterization was performed by liquid 
chromatography tandem mass spectrometry (LC-MS/MS). In order to obtain similar 
total ion current (TIC) and similar dynamic concentration range for each sample, for 
each of the liposomes, the same amount of corona proteins were injected for LC-











was calculated with eqn (1) as described in the Materials and methods. Usually, the 
spectral counts normalized by the protein molecular weight are used to  calculate a 
relative protein abundance and compare corona composition in different samples 
[15,16,30]. Here instead, the ion peak area was used for a more accurate intensity-
based quantification of the protein abundance [11,51]. It has been shown that the 
total protein approach (TPA) as obtained in single stage MS quantification is a robust 
measurement of protein concentration [52]. In order to compare the quantities of the 
different proteins identified within a corona sample, the raw quantitative pr otein 
values (peak areas) were first normalized by the protein mass, and then, in order to 
correct for differences in the amount of sample injected, by the sum of all normalized 
protein areas in the same sample. Thus the relative protein abundance is expre ssed 
as a percentage in respect to the total amount of proteins identified in each corona 
(see Materials and methods and Supplementary materials for more details).  
    The top 20 most abundant common proteins identified on all the 3 liposomal 
formulations in three independent corona preparations and isolations are shown in 
Fig. 6A. Additionally, in Supplementary Fig. S7 their abundance in the full human 
serum is also included as a reference for comparison (the complete list of identified 
proteins is provided in Supplementary Materials). The relative protein abundance of 
each protein was calculated with eqn(1) and the proteins were ranked as described in 
the Methods. It is important to notice the high reproducibility of corona composition 
in triplicate experiments, confirming that the optimized procedure allowed us to 
isolate corona proteins in a robust and reproducible manner. This also allowed us to 
compare the relative protein abundance for the different formulations and apply 
statistical analysis to determine the most statistically different proteins among the 
liposomes and the serum.  
    The comparison of the relative protein abundance of the top 20 corona proteins 
with their abundance in the full serum, as shown in Supplementary Fig. S7, confirmed 
that –as well established in the field- corona formation led to specific and strong 
enrichment of proteins on the liposomes [7–10]. As an example of this, the most 
abundant protein in serum, albumin, which alone constituted roughly 60% of the total 
proteins identified in serum, was not the most abundant protein in the corona (its 




values in the case of the zwitterionic liposomes). On the cont rary, low abundance 
proteins were highly enriched. For instance APOC1, which had around 0.15% 
abundance in full serum, was strongly enriched on the DOPC/G liposomes, where 
alone it constituted roughly 31% of the total amount of proteins in the corona.  
 
Figure 6. Analysis of the protein corona on different liposomal formulations. (A) Analysis of the 
top 20 most abundant proteins in the different liposomes. For each liposome, 3 replicate corona 
isolations and identifications have been performed and the relat ive abundance of each of the top 20 
proteins is indicated (calculated using eqn (1) and ranked as described in the Materials and methods). 
For each protein, the Area value obtained in each replicate sample is specified, while the balloon 











from black to red correspond to the p-values of the one way ANOVA analysis. (B) Venn diagram 
of the corona proteins identified on the 3 liposomes. (C) Z -score heat map of the most statistically 
different proteins in the corona forming on the 3 liposomes (p value ≤ 0.01), calculated as described 
in the Materials and methods.  
     
To better analyze how liposome formulation affected corona composition, Fig. 6A 
shows a similar analysis to determine the 20 most abundant proteins identified in all 
the 3 liposomes (without including the full serum). Additionally, in Supplementary 
Figs. S8A-C proteins were ranked based on the rank product of each formulation to 
show the 20 most abundant proteins in the DOPC, DOPC/G, and DOPG liposomes, 
respectively, together with their abundance in the other formulations, as well as in 
the serum, for comparison. The results clearly showed that the identity and relative 
abundance of the proteins adsorbed on the different liposomes varied strongly, 
confirming that tuning liposome formulation by mixing neutral and charged lipids in 
different ratio allowed to enrich corona of very different composition, and –as a 
result of that – to obtain formulations with very different uptake kinetics in cells (Fig. 
2). 
    The ranking of top 20 abundant proteins (Fig. 6A) showed – as expected - 
enrichment of lipoproteins, immunoglobulins and other proteins on all samples, as 
commonly observed in similar corona studies [14–16]. Several apolipoproteins 
including APOA1, APOA2, APOC1, APOC2 and APOE were included in the top 20 
list, but their amount on three liposomes was different. To evaluate the effect of lipid 
composition on corona formation, a Venn diagram was used to show the common and 
unique corona proteins identified on the three liposomes (Fig. 6B). A first important 
observation is that the number of corona proteins identified on DOPG liposome and 
DOPC/G liposome (281 and 258 proteins, respectively) was much higher than for 
DOPC liposome (186 proteins). Interestingly, almost all of the proteins identified on 
DOPC liposomes were in common with the other formulations (170 proteins out of 
186 total proteins identified), whereas by adding increasing amounts of the 
negatively charged DOPG lipid, the number of unique corona proteins on the 
liposomes increased from 4 unique proteins for DOPC, to 35 and up to 60 in the case 
of DOPC/G and DOPG respectively. Thus, adding increasing amounts of the 




increased the total amount of absorbed proteins (Fig. 5C) but also protein  variety and 
the presence of unique proteins.  
    A Z-score heat map allowed to have a closer look at the most statistically different 
proteins adsorbed on the different formulations (Fig. 6C, p value ≤ 0.01). From this 
graph and the list of the top 20 most abundant proteins in each formulation 
(Supplementary Figs. S8A-C) some interesting conclusions can be drawn. First, 
immunoglobulins were among the most abundant proteins on DOPC liposomes 
(Supplementary Fig. S8A). Additionally, DOPC showed enrichment of several 
unique lipoproteins including APOB, APOM, APOD and APOC3 which had higher 
Z-score on the DOPC liposomes in comparison to the other formulations, although 
their relative abundance in the DOPC corona was not very high (Supplementary Fig. 
S8A). Enriched proteins distinguishing the corona of a specific formulation may have 
strong biological impact even if their relative abundance is low. Similarly, the 
complement proteins C4BPA and C4BPB had higher Z-score on the DOPC liposomes. 
On the opposite side, on the anionic DOPG liposomes, a different set of lipoproteins 
was enriched, including for instance APOC1, APOH and APOE (the first two highly 
abundant also on the mixed DOPC/G liposomes). Additionally, it was interesting to 
note that several of the  proteins most statistically different on DOPG liposomes (Fig. 
6C), such APOE, VTNC and THRB were proteins that – based on their isoelectric 
point (pI) [53]– have a negative charge in a physiological environment. This 
suggested that corona composition cannot be predicted solely based on the particle 
surface charge [9]. A classification of the identified corona proteins based on their 
pI is included in Supplementary Fig. S9. Despite the variation of protein pI 
distribution among the different formulations, for all liposomes more than 50%  of 
the corona proteins had a pI < 7.4 thus a negative charge in physiological 
environment. This may contribute to the so-called ‘normalization’ effect of the 
corona in serum, where most nanomaterials, regardless of their initial charge, tend to 
similar (low and slightly negative) zeta potential upon corona formation, as indeed 
we showed also for these liposomes (Fig. 1B) [9].    
    As a final step, we tried to connect uptake efficiency and corona composition. In 
agreement with our results, a strong positive correlation has been reported between 











in vitro [54] and in vivo [55]. Thus, in our case, with the addition of the anionic 
DOPG lipid, liposomes with increased amount and larger variety of absorbed proteins 
were obtained, and they also showed higher uptake rate in HeLa cells, especially in 
the first hours of exposure. It is important to stress that all formulations had 
comparable zeta potential once dispersed in serum, as a consequence of protein 
adsorption and corona formation, regardless of the very different charge and zeta 
potential in pristine conditions (Fig. 1B). We have recently shown that when different 
coronas form on silica nanoparticles and DOPG liposomes, nanoparticles are 
recognized by different cell receptors and cells use different mechanisms for their 
uptake [38]. Similarly, Digiacomo et al. showed that the mechanism of 
internalization of liposomes was changed from micropinocytosis to clathrin -
dependent endocytosis after corona formation [56]. Therefore, in the current study, 
the very different uptake kinetics of DOPC, DOPC/G and DOPG liposomes were 
likely a result of specific interactions of their different corona components with cell 
receptors and activation of different uptake mechanisms.     
    Additionally, Ritz et al. correlated the enrichment of corona proteins on 
polystyrene nanoparticles with their cellular uptake [20], and they reported that a 
higher relative amount of THRB, VNTIII, VTN, ITIH4, PLF4 and APOH correlated 
with a higher cellular uptake, while a negative correlation was observed between 
APOA4, APOC3, ALBU and CO3 and uptake. In our case, immunoglobulins, albumin 
and the lipoproteins APOC1, APOA1 and APOA2 were present in all of the coronas , 
but in different abundance for the different formulations. In agreement with the 
results by Ritz et al., APOC3 was most abundant and most statistically different in 
the corona of DOPC liposomes for which the lower uptake was observed, while 
THRB, VTNC, PLF4 and APOH were most abundant and enriched on the DOPG 
liposomes, which had the highest cellular uptake efficiency. In line with these results, 
given the higher enrichment of APOC2 and APOM on the DOPC liposomes, it may 
be interesting to determine whether the presence of these proteins in the corona leads 
to lower uptake by cells, as demonstrated for APOC3. Similarly, the specific 
enrichment of APOE on the DOPG liposomes may explain the higher uptake of these 
liposomes. It was previously reported that PG lipids promote interactions with the 




functionalized nanoparticles may enable access to the brain via the blood brain 
barrier [57–59]. Based on these observations, it would be interesting to explore 
whether DOPG liposomes could be exploited as a strategy to target the LDL receptor  
or promote transcytosis to the brain.  
 
4. Conclusions 
    It is nowadays well established that nano-sized materials including nanomedicines 
once applied in a biological environment are modified by adsorption of a layer of 
biomolecules resulting in a corona which strongly affects the behavior on cells [7–
10]. Growing evidence has indicated that this layer can be recognized by specific cell 
receptors, opening up interesting possibilities of tuning corona composit ion in order 
to affect nanomedicine uptake and behavior on cells [24,25,38]. Within this 
framework here we have prepared and optimized a liposomes series of tailored 
surface properties by mixing zwitterionic DOPC and anionic DOPG lipids in different 
ratios. All liposomes gave homogeneous dispersions in serum and remained stable 
up to 24 h in cell culture conditions. Additionally, they were internalized by cells as 
intact nanoparticles via energy dependent mechanisms and trafficked along the endo -
lysosomal pathway towards the lysosomes. However the different formulations 
showed very different uptake efficiency and kinetics : by adding increasing amounts 
of the negative lipid DOPG, liposomes with higher serum protein binding capacity 
were obtained, and – in line with other similar results - the protein binding capacity 
had strong positive correlation with uptake efficiency by cells [49,50]. Thus we 
optimized procedures for corona isolation to avoid contamination of serum particles 
and aggregates and we have identified the proteins recovered on the different 
liposomes by mass spectrometry. Thanks to the optimized methods, replicate 
experiments showed excellent reproducibility in the isolated corona proteins. 
Additionally, ion peak area and single stage MS quantification were used for a more 
accurate intensity-based quantification of the protein abundance and thanks to the 
replicate isolations and mass spectrometry data, statistical analysis was applied to 
compare the corona composition on the different formulations. The amount and 
identity of the proteins adsorbed varied strongly, as also the observed uptake 











liposomes in cell media following corona formation, it is likely that the observed 
differences in uptake behavior on cells were due to speci fic interactions with corona 
proteins and activation of different mechanisms of uptake, as opposed to simple 
charge differences. Thus, overall, we showed that by mixing lipids to different ratios, 
liposome series of tailored surface properties can be prepared to gradually tune 
corona composition in a systematic way. Tuning corona composition allowed us to 
obtain liposomes with very different uptake behavior on cells. Thus, formulations 
can be optimized to achieve the desired uptake efficiency and kinetic profiles as 
required for specific applications. Additionally, careful controls were included  to 
exclude the presence of particle agglomeration during corona isolation and eventual 
residual free proteins which could confuse the results.  
    At a broader level, further studies are required in order to determine how uptake 
efficiency by cells correlates with liposome outcomes in vivo [40]. Additionally, 
using similar approaches as we showed here to measure uptake by macrophages, 
further insights on effects of corona composition on clearance by the immune system 
could be obtained. Thus, novel strategies to prolong liposome circulation time in vivo 
could also be discovered [60].  
    Overall, the correlation of corona composition and uptake by cells (or cle arance 
by macrophages) can be used as a novel tool to identify proteins which correlate with 
higher and-or lower uptake by cells [16,20]. Recent studies are indicating that the 
corona may interact with cell receptors via patterns or novel epitopes forming after 
corona formation, and not only by interactions of individual proteins with their 
specific receptors. Thus the simple identity of the proteins in the corona may not 
capture all possible interactions with cell receptors and, similarly, patterns of corona 
proteins together may be responsible of nanopartic le outcomes at organism level 
[13,61]. Nevertheless, by studying the specific role of individual proteins identified 
in the corona in mediating interactions with their corresponding cell receptors and 
promoting or blocking nanoparticle uptake, additional strategies to control 
nanomedicine outcomes on cells may be developed, including for reducing their 
clearance [20,23].  
    Clearly, more work is needed to be able to predict corona formation and to predict 




understanding of the complex modifications nano-sized materials encounter in 
biological environments and their consequences on their outcomes at cell and 
organism level is needed to guide the design of successful nanomedicines. 
Approaches such as those presented can be used to optimize formulations with 
desired properties for specific applications.  
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Supplementary materials and methods 
Shotgun LC/MS-MS analysis 
    Tryptic peptides were analyzed with an UltiMate 3000 RSLC UHPLC system 
(Dionex) linked to an Orbitrap Q Exactive Plus mass spectrometer (Thermo Fisher 
Scientific) performing in a data-dependent acquisition (DDA) mode. For each sample, 
5 µl of the digested peptide solution (corresponding to 3 µg protein) was enriched 
onto a Acclaim PepMap 100 C18 trap column (Dionex, #160454; 300 µm i.d. × 5 mm, 
5 µm, 100 Å) with 0.1% formic acid (FA) at a flow rate of 20 µl/min. Peptide mixtures 
were then separated on a 75 µm i.d. × 500 mm Acclaim PepMap RSLC C18 analytical 
column (Dionex, #164540) with 2 µm resin size and 100 Å pore size. The analytical 
column was kept at 40 °C while performing a 90 min linear gradient from 3% to 50% 
of eluent B (ACN containing 0.1% FA) in eluent A (H 2O containing 0.1% FA), then 
passing in 1 min from 50% to 80% of eluent B, where it remained  for 9 min, and then 
passing  in 1 min back to 3% eluent B. Finally, the instrument was left equilibrating 
for 29 min before the next injection. The flow rate was set at 300 nl/min. Mass spectra 
were acquired from 300 to 1650 m/z at 70000 resolution using a dynamic exclusion 
of 20 s. Higher energy collisional dissociation (HCD) fragment analysis was 
collected from the maximum 15 most abundant precursor ions with a charge state of 
2+ to 6+, between 200 and 2000 m/z at 17500 resolution with an 5 × 10 4 AGC target 
value, a maximum ion injection time of 50 ms, a normalized collision energy of 28%, 
an isolation window of 1.8 m/z, an underfill ratio of 1%, and an intensity threshold 
of 1 × 104. For each liposome, 3 independent corona isolation experiments were 
performed and were analyzed by LC-MS/MS separately. 
 
Data processing and bioinformatics analysis  
    The raw data from DDA LC-MS/MS were analysed with PEAKS Studio software 
(version 8.5) [1] using the SwissProt human database (20197 entries; downloaded on 




Carbamidomethylation was set as fixed modification and methionine oxidation and 
acetylation of protein N-terminal as variable modifications with 3 maximum variable 
modifications per peptide, along with 0.02 Da fragment mass tolerance, 10.0 ppm 
precursor mass tolerance and ≤ 0.1% false discovery rates (FDR) for peptide -
spectrum matches (PSMs).  
    A relative quantitation of the identified proteins was performed by determining 
the ion peak area (Area), which was the sum of the areas of all unique peptides 
mapping to the protein group. For each identified protein, the protein Area was 
normalized by the protein mass and expressed as the relative protein abundance 
according to the following equation: 
Areax = [(Area/Mw)x / ∑ (Area/Mw)𝑛𝑖=1 i] × 100                                  (1)  
    Based on the calculated Area value, data were further analyzed and visualized with 
an in-house developed script in R (version 3.4.3) and R Studio (version 1. 0.143). 
The quantitative Area values were subjected to median scale normalization [2]. To 
compare the profile of proteins adsorbed on the different liposomes, a Venn diagram 
was created with the R package “VennDiagram” including the proteins detected in at 
least 2 out of the 3 replicates. The R package “ComplexHeatmap” was then used for 
showing the Z-score heat map of the most statistically different proteins (p value ≤ 
0.01) between the various liposomes determined by one way ANOVA analysis. In 
order to determine the most abundant proteins in the corona, the Rank Product 
method [3] was applied to rank the identified proteins as follows: in Fig. 6A and 
Supplementary Fig. S7 to rank the most abundant corona proteins identified on all of 
the 3 different formulations (3 liposomes with 3 replicate isolations each, thus 9 
corona samples in total); and in Supplementary Figs. S8A-C instead to rank the 
corona proteins of each liposome (in 3 replicate isolations), thus the corona proteins 
of DOPC, DOPC/G and DOPG liposomes, respectively, in Supplementary Figs. S8A -
B-C. In these plots, the Rank Products allow to get the rank of abundant proteins in 
the different replicates and sample groups in a non-parametric way. In summary, 
proteins are ranked from higher to lowest abundance in all analyzed samples and for 
each protein, the ranks in multiple samples are multiplied, in order to obtain the so -
called rank product for that protein. The obtained rank products for each protein were 











is displayed in the plots. The “ggplot2” package was then used to visualize the top 
20 proteins according to the calculated rank product. For each protein, the Area value 
obtained for each replicate sample following eq.1 is specified, while the balloon area 
shows the relative percentage of the median scale normalized protein abundance. The 
colors from black to red correspond to the p-values of one way ANOVA analysis. In 
Fig. 6A and Supplementary Figs. S8A-C, statistical analysis was performed on all 
replicates of the 3 liposomes while in Supplementary Fig. S7, in order to show 
differences in respect to full serum composition, statistical analysis was performed 
on all replicates of the 3 liposomes and of the full human serum.  
 
Liposome uptake by flow cytometry in energy depleted cells  
    In order to measure potential uptake in energy depleted cells, 5 × 10 4 cells per well 
were seeded in a 24-well plate. After 24 h incubation in cMEM, cells were washed 
with serum free medium 3 times and incubated with 5 mg/ml sodium azide (Merck) 
dissolved in cMEM or hsMEM for 30 min to deplete cell energy. 50 µg/ml liposome 
dispersions were then prepared by dilution of the liposome stock into cMEM or 
hsMEM with and without 5 mg/ml sodium azide. After exposure to the liposomes in 
the different conditions, cells were collected for flow cytometry measurements as 
described above. In cells exposed to DOPC liposomes in sodium azide for 3 h, flow 
cytometry showed double peaks in the cell fluorescence distribution, with a portion 
of cells with higher fluorescence than cells exposed to liposomes in normal 
conditions. These are likely dying cells with compromised cell membrane 
permeability due to the toxic effects of sodium azide (see also Supplementary Fig. 
S3). Similar effects were observed also in cells exposed to free SRB after 3 h in 
sodium azide. In these cases double scatter plots of forward scatter versus 
fluorescence were used to exclude this subpopulation to calculate the median 
fluorescence of all other cells.   
 
Fluorescence imaging 
    For fluorescence microscopy, 1.5 × 105 cells were seeded in 35 mm dishes with a 




medium for 3 times and incubated with 50 µg/ml liposomes in cMEM or hsMEM 
respectively for 3 h at 37 °C. To visualize the lysosomes, cells were incubated for 30 
min with 100 nM LysoTracker Deep Red (Thermo Fisher Scientific) in cMEM 
followed by 3 washes with serum free MEM. Then, cells were washed with PBS 3 
times again and nuclei stained by incubation with 1 µg/ml Hoechst 33342 Solution 
in cMEM (Thermo Fisher Scientific) for 5 min. Finally, cells were washed once with 
PBS and incubated in cMEM for imaging. Cells exposed to liposomes in cMEM were 
imaged using a Leica TCS SP8 fluorescence confocal microscope (Leica 
Microsystems) equipped with a 405nm laser for Hoechst excitation, a 552 nm laser 
for liposomes and a 640 nm for LysoTracker Deep Red. Cells exposed to liposomes 
in hsMEM were imaged using DeltaVision Elite (GE Healthcare Life Science) with 
DAPI filter for Hoechst excitation, TRITC filter for liposomes and CY5 filter for 
LysoTracker. Movies were recorded for up to 2 min by acquiring an image every 10 
sec for cells exposed to DOPC and DOPG liposomes and every 5 sec for cells exposed 
to DOPC/G liposomes. ImageJ software (http://www.fiji.sc) was used for image 
processing and brightness and contrast were adjusted using the same setting for all 












Supplementary Table S1.  Description of all liposome formulations investigated. 10 mg lipid 
mixtures at different molar ratio were prepared and used to prepare liposomes as described in the 







Supplementary Figure S1.  Size distribution and zeta potential measurements of cationic liposomes 
in different media. (A-B) Size distribution by intensity obtained by dynamic light scattering of 
cationic liposomes of different lipid composition. 50 µg/ml DOTAP, DOTAP -DOPE and DOPE-DC 
CHOL liposomes dispersed in PBS, cMEM (A) and hsMEM (B) were characterized by dynamic light 
scattering as described in the Materials and methods. Preparation by extrusion allowed to obtain 
liposomes with narrow size distributions which were stable in PBS. However, dispersion in cMEM 
and in hsMEM led to strong agglomeration. Because of this, negatively charged and zwitterionic 
liposomes which remained stable in cMEM (as shown in Fig. 1) were used for further analysis in 
serum and on cells. (C) Zeta potential of cationic liposomes dispersed in PBS, cMEM and hsMEM. 
All liposomes had positive zeta potential in PBS, while they all ac quired comparable slightly 
negative zeta potential when dispersed in media with serum, as a consequence of protein adsorption 














Supplementary Figure S2. (A-B) Uptake of liposomes in cMEM (A) and medium with 25 mg/ml 
human serum (B). HeLa cells were exposed to 50 µg/ml DOPC, DOPC/G and DOPG liposomes in 
cMEM (A) and medium supplemented with 25 mg/ml human serum (B) for increasing times, 
followed by flow cytometry to measure the cell fluorescence intensity. On the left: nanoparticle 
uptake kinetics were different for the different formulations, with DOPC showing lower uptake in 
the first hours. Addition of high concentration of human serum (B) reduced uptake levels. On the 
right: uptake of each of the liposomes by HeLa cells in standar d conditions or in the presence of 5 
mg/ml sodium azide to deplete cell energy ( - and + NaN3) (see Materials and methods for details). 






Supplementary Figure S3.  Liposome stability and control uptake studies with free SRB and energy 
depleted cells. (A) Removal of excess free SRB after liposome preparation. After liposome extrusion, 
the excess free SRB was removed using a spin column (see Materials and methods for details). The 
picture on the left shows efficient removal of the residual free SRB in the spin column. Then, 
liposomes stored in PBS were loaded on a Sepharose CL-4B column in order to separate eventual 
residual free SRB or SRB leaking. Fractions eluting from the column were collected for fluorescence 
measurement to detect SRB: the obtained elution profiles confirmed that for all formulations, all 
SRB eluted in fractions 6-11 corresponding to liposomes, and no free SRB released from liposomes 
was detected. The formulations were stable in PBS for at least 1 month. (B) Elution profiles of 
liposomes after interaction with human serum and corona formation. Briefly, 0.5 mg/ml liposomes 
were incubated with 40 mg/ml human serum in a Thermo-Shaker at 37 °C, 250 rpm, to mimic cell 
experiment conditions. After 1 h incubation, samples were loaded on a Sepharose CL -4B column 
and fractions eluting from the column were collected for absorbance measurements at 280 and 560 
nm to detect –respectively - proteins and SRB. The results showed that after interaction with serum 
and corona formation, for DOPC and DOPC/G liposomes most SRB remained in the liposomes, 
while for DOPG liposomes dye leakage was observed. (C) Uptake of 5 µM free SRB in hsMEM by 
HeLa cells in standard conditions and in energy-depleted cells. Briefly, 5 µM free SRB 
(corresponding to the concentration of dye encapsulated in 50 µg/ml liposomes) was exposed to 
cells in standard conditions and in the presence of 5 mg/ml sodium azide to deplete cell energy. The 











had only minor effects on the uptake of the free dye, possibly because of compromised cell 
membrane permeability in energy depleted cells. Indeed, in cells exposed to SRB in  sodium azide 
for 3 h, flow cytometry showed double peaks in the cell fluorescence distribution, with a portion of 
cells with higher fluorescence than cells exposed to SRB in normal conditions. These are likely 
dying cells with compromised cell membrane pe rmeability due to the toxic effect of sodium azide. 
In these cases double scatter plots of forward scatter versus fluorescence were used to exclude this 
subpopulation to calculate the median fluorescence of all other cells. In the middle panel, the same 
data are compared to the uptake levels of 50 µg/ml liposomes encapsulating the same amount of 
SRB (dashed lines, after 3 h exposure in standard conditions). This comparison clearly shows that 
the uptake of free SRB was lower in all cases, and especially in c omparison to the uptake levels of 
DOPC/G and DOPG liposomes. In the right panel, the uptake levels of free dye and liposomes after 
3h exposure in energy-depleted cells were normalized by the uptake in standard conditions in order 
to compare sodium azide inhibition efficiency. The results showed that sodium azide had only minor 
effects on the uptake of free SRB (around 25% reduction), but much stronger effects on liposome 
uptake (50 % reduction for DOPC and 70-80% for DOPC/G and DOPG). Overall, these results  
confirmed that the florescence measured in cells exposed to the liposomes was primarily due to the 
energy-dependent uptake of SRB-labelled liposomes. (D) Uptake of 50 µg/ml 0.5 mol% TopFluor 
PE labeled liposomes in hsMEM by HeLa cells in standard conditio ns or in the presence of 5 mg/ml 
sodium azide to deplete cell energy ( - and + NaN3). In these examples, liposomes were labelled 
using a fluorescently TopFluor PE lipid instead of SRB. The results showed that uptake was present 
also in energy depleted cells , possibly as a consequence of transfer of the lipophilic label from the 
liposomes to cell membranes. Because of this, liposomes labelled with the hydrophilic SRB were 
















Supplementary Figure S4.  Fluorescence microscopy images of HeLa cells exposed to  liposomes 
and free SRB in cMEM. Briefly, HeLa cells were exposed for 3 h to 50 µg/ml DOPC (A), DOPC/G 
(B) and DOPG (C) liposomes in cMEM or 5 µM SRB (D). Blue: Hoechst stained nuclei.  Red: SRB 
stained liposomes or free SRB. Green: LysoTracker stained lysosomes (see Materials and methods 
for details). Scale bar: 10 µm. The same samples shown in panels A and D were imaged with 
different settings to allow detection of lower signals in the  cells by increasing the detector gain. 
This allowed us to confirm uptake and accumulation in the lysosomes of the DOPC liposomes (panel 







Supplementary Figure S5.  Effect of centrifugation on liposome stability. Size distribution by 
intensity obtained by dynamic light scattering of 50 µg/ml DOPC liposomes in PBS (A), and 500 
µg/ml DOPC liposomes in MEM supplemented with 40 mg/ml FBS after dispersion (B) an d after 
corona isolation by centrifugation (C-D). Preparation by extrusion allowed to obtain liposomes with 
narrow size distributions which were stable in PBS and after dispersion in cMEM (A, and B 
respectively, with a small peak around 10 nm detected in F BS from the free proteins in excess in 
the medium). The liposomes in FBS where then spin down at 16000 g for 1 hour to isolate the 
liposome-corona complexes from the excess free proteins. However, DLS showed that after both 1 
and 2 centrifugations (C and D, respectively) it was not possible to obtain good dispersions and 
strong agglomeration was detected. Because of this, isolation of the corona coated liposomes was 














Supplementary Figure S6.  Isolation of corona-coated liposomes from human serum (HS). (A) Left 
panel: Elution profile of full human serum (HS). Briefly, 1 ml 71mg/ml HS was loaded into a 
Sepharose CL-4B column and the protein elution profile was obtained (see Materials and methods 
for details). The results showed that some large objects eluted early (fractions 7 -9), in the same 
fractions in which free liposomes also eluted (see Figure 4 and panel B for comparison). Right 
panels: size distribution by intensity obtained by DLS of fractions 7 -8-9. DLS showed that in these 
fractions objects of around 100 nm were detected. (B) Left panel: Elution profile of DOPC 
liposomes after 1 h incubation with human serum. Briefly, 500 µg/ml liposomes were mixed with 
40 mg/ml human serum and the obtained corona-coated liposomes were separated by SEC. The 
elution profile was comparable to that observed for the full human serum (panel A). Right panels: 
size distribution by intensity obtained by DLS of fractions 7 -8-9. DLS showed that in these fractions, 
as observed for full human serum, objects of around 100 nm were detected. The comparison of 
elution profiles and DLS results for full serum and liposomes dispersed in serum (panels A and B, 
respectively) clearly showed that large particles of sizes comparable to the liposom es were present 
in the serum and eluted in the same fractions as the liposomes. These particles would affect corona 
isolation in full human serum. (C-D) SDS-PAGE images of (C) fractions 7-11 from the elution of 
full human serum and (D) fractions 8-13 from the elution of DOPC liposomes dispersed in full 
human serum. For each fraction, 30 µl were loaded in each well. The results confirmed that many 
proteins were recovered from full serum (C) in the same fractions in which liposomes eluted (D). 






Supplementary Figure S7.  Analysis of the top 20 most abundant proteins in the different liposomes 
and their abundance in full human serum. For each liposome, 3 replicate corona isolations and 
identifications have been performed and additionally 3 samples of full human serum were analyzed. 
For each sample, the relative abundance of each of the top 20 proteins in the different liposomes is 
indicated (calculated using eqn (1) and ranked as described in the Materials and methods), and their 
abundance in full human serum is also included for comparison. For each protein, the Area value 
obtained in each replicate sample is specified, while the balloon area shows the relative percentage 
of the median scale normalized protein abundance. The colors from black to red correspond to the 
p-values of the one way ANOVA analysis on all coronas formed on all liposomes and on the serum 
(see Materials and methods for details). The results clearly sho wed that excellent reproducibility 
was obtained across replicates experiments and that corona formation led to strong enrichment of 
specific proteins on the liposomes in respect to their natural abundance in full human serum. 
















Supplementary Figure S8. Analysis of the top 20 most abundant proteins in the corona forming on 
–respectively – DOPC (A), DOPC/G (B), and DOPG (C) liposomes. For each liposome, 3 replica te 
corona isolations and identifications have been performed and additionally 3 samples of full human 
serum were analyzed. The 20 most abundant proteins in the corona of DOPC (A), DOPC/G (B), and 
DOPG (C) liposomes are shown and their relative abundance is  indicated, (calculated using eqn (1) 
and ranked as described in the Materials and methods), together with their abundance in the other 
liposome formulations and the full human serum, for comparison. For each protein, the Area value 
obtained in each replicate sample is specified, while the balloon area shows the relative percentage 
of the median scale normalized protein abundance. The colors from black to red correspond to the 
p-values of the one way ANOVA analysis on all coronas formed on all liposomes (se e Materials 
and methods for details).  These graphs allow to see the top 20 most abundant proteins in each of 
the liposomes. The results clearly showed that different corona were formed on the different 













Supplementary Figure S9. Classification based on isoelectric point (pI) of the corona proteins 
identified in the corona formed on DOPC, DOPC/G and DOG liposomes in human serum. The results 
are the mean and standard deviation over 3 replicates of the data obtained from 3 independent corona 
isolations for each formulation. More than 50% of the identified proteins had a pI < 7.4 thus they 
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